NCT05870657View on ClinicalTrials.gov

Adherence and Persistence to Inclisiran Among Early Users in Germany

CompletedOBSERVATIONAL
Enrollment

1,109

Participants

Timeline

Start Date

February 16, 2022

Primary Completion Date

May 12, 2022

Study Completion Date

May 12, 2022

Conditions
High Levels of Low-density Lipoprotein Cholesterol
Trial Locations (1)

Unknown

Novartis, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY